Haleon reboots digital post demerger from GlaxoSmithKline
With its demerger journey spiked the transformation need, the article decodes how Haleon reboots its strategy
With its demerger journey spiked the transformation need, the article decodes how Haleon reboots its strategy
The newly launched asthma drug by the London-based drug maker, GlaxoSmithKline (GSK) is not cost-effective, reports an independent nonprofit organization.
After the Indian government has banned the sale of fixed dose combination drugs (FDCs) like Corex, Phensedyl and Vicks Action 500 Extra, the pharmaceutical
SB Pharmco Puerto Rico Inc., a subsidiary of GlaxoSmithKline, PLC (GSK), has agreed to plead guilty to charges relating to the manufacture and distribution of certain adulterated drugs made at GSK’s now-closed Cidra, Puerto Rico, manufacturing facility.
"Every year, health care fraud costs American taxpayers billions of dollars and undermines the integrity of the health care programs on which so many of us depend," said Assistant Attorney General West.
Glaxo said it would invest more than £200m in the US company and that they would initially focus on speeding up development of Vir's antibody drugs, which could be used to treat Covid-19.
GSK has agreed to sell its entire stake in Unilever's Indian business for about 254.8 billion rupees ($3.35 billion) on the open market, cashing in late from the sale of the Horlicks brand.
GlaxoSmithKline (GSK) is creating a data-focused culture and a global machine-learning team.